NCT01255423View on ClinicalTrials.gov

Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Applied 4 Times Daily in Subjects With Acute Ankle Sprain

PHASE3CompletedINTERVENTIONAL
Enrollment

206

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Ankle Sprain
Interventions
DRUG

Diclofenac sodium topical gel 1%

Diclofenac sodium topical gel 1%, 4 times daily

DRUG

Placebo

Placebo, 4 times daily

Trial Locations (9)

Unknown

Birmingham

Aventura

Hialeah

Miami

Berlin

Columbia

El Paso

Houston

Salt Lake City

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT01255423 - Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Applied 4 Times Daily in Subjects With Acute Ankle Sprain | Biotech Hunter | Biotech Hunter